IONS vs ROL · rev $514.0M vs P/E 41, rev $1.99B
Ionis Pharmaceuticals Inc (IONS) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
IONS currently screens at market cap $12.28B. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the IONS and ROL stock pages for the full models.
Not investment advice.